These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29945188)

  • 21. On measuring selection in cancer from subclonal mutation frequencies.
    Bozic I; Paterson C; Waclaw B
    PLoS Comput Biol; 2019 Sep; 15(9):e1007368. PubMed ID: 31557163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MUSE-XAE: MUtational Signature Extraction with eXplainable AutoEncoder enhances tumour types classification.
    Pancotti C; Rollo C; Codicè F; Birolo G; Fariselli P; Sanavia T
    Bioinformatics; 2024 May; 40(5):. PubMed ID: 38754097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling gene-wise dependencies improves the identification of drug response biomarkers in cancer studies.
    Nikolova O; Moser R; Kemp C; Gönen M; Margolin AA
    Bioinformatics; 2017 May; 33(9):1362-1369. PubMed ID: 28082455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. vulcanSpot: a tool to prioritize therapeutic vulnerabilities in cancer.
    Perales-Patón J; Di Domenico T; Fustero-Torre C; Piñeiro-Yáñez E; Carretero-Puche C; Tejero H; Valencia A; Gómez-López G; Al-Shahrour F
    Bioinformatics; 2019 Nov; 35(22):4846-4848. PubMed ID: 31173067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TiMEx: a waiting time model for mutually exclusive cancer alterations.
    Constantinescu S; Szczurek E; Mohammadi P; Rahnenführer J; Beerenwinkel N
    Bioinformatics; 2016 Apr; 32(7):968-75. PubMed ID: 26163509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of cancer driver genes through network-based moment propagation of mutation scores.
    Gumpinger AC; Lage K; Horn H; Borgwardt K
    Bioinformatics; 2020 Jul; 36(Suppl_1):i508-i515. PubMed ID: 32657361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PCIG: a web-based application to explore immune-genomics interactions across cancer types.
    Pedrola A; Franch-Expósito S; Lahoz S; Esteban-Fabró R; Dienstmann R; Bassaganyas L; Camps J
    Bioinformatics; 2022 Apr; 38(8):2374-2376. PubMed ID: 35179562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NIMBus: a negative binomial regression based Integrative Method for mutation Burden Analysis.
    Zhang J; Liu J; McGillivray P; Yi C; Lochovsky L; Lee D; Gerstein M
    BMC Bioinformatics; 2020 Oct; 21(1):474. PubMed ID: 33092526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PersonaDrive: a method for the identification and prioritization of personalized cancer drivers.
    Erten C; Houdjedj A; Kazan H; Taleb Bahmed AA
    Bioinformatics; 2022 Jun; 38(13):3407-3414. PubMed ID: 35579340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
    Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
    Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting the functional consequences of cancer-associated amino acid substitutions.
    Shihab HA; Gough J; Cooper DN; Day IN; Gaunt TR
    Bioinformatics; 2013 Jun; 29(12):1504-10. PubMed ID: 23620363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PRESM: personalized reference editor for somatic mutation discovery in cancer genomics.
    Cao C; Mak L; Jin G; Gordon P; Ye K; Long Q
    Bioinformatics; 2019 May; 35(9):1445-1452. PubMed ID: 30247633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotations.
    Lochovsky L; Zhang J; Fu Y; Khurana E; Gerstein M
    Nucleic Acids Res; 2015 Sep; 43(17):8123-34. PubMed ID: 26304545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hidden Markov models lead to higher resolution maps of mutation signature activity in cancer.
    Wojtowicz D; Sason I; Huang X; Kim YA; Leiserson MDM; Przytycka TM; Sharan R
    Genome Med; 2019 Jul; 11(1):49. PubMed ID: 31349863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Personalized regression enables sample-specific pan-cancer analysis.
    Lengerich BJ; Aragam B; Xing EP
    Bioinformatics; 2018 Jul; 34(13):i178-i186. PubMed ID: 29949997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. OncodriveROLE classifies cancer driver genes in loss of function and activating mode of action.
    Schroeder MP; Rubio-Perez C; Tamborero D; Gonzalez-Perez A; Lopez-Bigas N
    Bioinformatics; 2014 Sep; 30(17):i549-55. PubMed ID: 25161246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nozzle: a report generation toolkit for data analysis pipelines.
    Gehlenborg N; Noble MS; Getz G; Chin L; Park PJ
    Bioinformatics; 2013 Apr; 29(8):1089-91. PubMed ID: 23419376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. G3viz: an R package to interactively visualize genetic mutation data using a lollipop-diagram.
    Guo X; Zhang B; Zeng W; Zhao S; Ge D
    Bioinformatics; 2020 Feb; 36(3):928-929. PubMed ID: 31393560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. accuMUlate: a mutation caller designed for mutation accumulation experiments.
    Winter DJ; Wu SH; Howell AA; Azevedo RBR; Zufall RA; Cartwright RA
    Bioinformatics; 2018 Aug; 34(15):2659-2660. PubMed ID: 29566129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A weighted exact test for mutually exclusive mutations in cancer.
    Leiserson MD; Reyna MA; Raphael BJ
    Bioinformatics; 2016 Sep; 32(17):i736-i745. PubMed ID: 27587696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.